romiplostim (NPLATE°) and chronic immune thrombocytopenia from one year of age

首页> 外文期刊>Prescrire international >romiplostim (NPLATE°) and chronic immune thrombocytopenia from one year of age

【24h】

romiplostim (NPLATE°) and chronic immune thrombocytopenia from one year of age

机译：romiplosim（NOLD°）和慢性免疫血小板减少来自一年的年龄

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Like eltrombopag, romiplostim increases platelet counts in the short term in children after standard treatments have failed, but with no demonstrated effect in reducing the number of bleeding episodes. Its adverse effect profile in children is similar to that in adults, and additionally includes oropharyngeal and abdominal pain, and rhinitis. There is a risk of error when preparing the drug for administration.

机译：与eltrombopag一样，在标准治疗失败后，romiplostim会在短期内增加儿童的血小板计数，但在减少出血次数方面没有明显效果。其对儿童的不良反应与成人相似，另外还包括口咽和腹痛以及鼻炎。准备给药时有出错的风险。

著录项

来源
《Prescrire international》 |2021年第222期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Strategy changes in Chinese hematologists' diagnosis and treatment of primary immune thrombocytopenia across 10 years (2009-2018) [J] . Hong-Hui Wang, Hui Bi, Lei Zhang, 中华医学杂志（英文版） . 2019,第022期
2. Association between Selenium in Soil and Diabetes in Chinese Residents Aged 35-74 Years: Results from the 2010 National Survey of Chronic Diseases and Behavioral Risk Factors Surveillance [J] . WANG Qi Qi, ZHAO Wen Hua, YAO Hong Yan, 生物医学与环境科学（英文版） . 2020,第004期
3. Population attributable risks of cigarette smoking for deaths of all causes, all cancers and other chronic diseases among adults aged 40-74 years in urban Shanghai, China [J] . Ying-Ying Wang, Wei Zhang, Hong-Lan Li, 中国癌症研究（英文版） . 2015,第001期
4. Efficacy of pegylated interferon-alpha-2a plus ribavirin for patients aged at least 60 years with chronic hepatitis C [J] . ZHENG Ying-ying, FAN Xiao-hong, WANG Li-feng, 中华医学杂志（英文版） . 2012,第011期
5. Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia ( ITP ITP ) for up to 1?year and in those with chronic ITP ITP for more than 1?year: a subgroup analysis of integrated data from completed romiplostim studies [J] . Kuter David J., Newland Adrian, Chong Beng H., British Journal of Haematology . 2019,第3期

机译：成年患者的Romiplostim患者新诊断或持续的免疫血小板减少症（ITP ITP）最多1年，并在慢性ITP ITP的那些中超过1？一年：来自完成的romiplosim研究的综合数据亚组分析
6. Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged >= 65 years with immune thrombocytopenia [J] . Michel Marc, Wasser Jeffrey, Godeau Bertrand, Annals of hematology . 2015,第12期

机译：≥65岁的免疫性血小板减少症患者中血小板生成素受体激动剂romiplostim的疗效和安全性
7. Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program. [J] . Khellaf M, Michel M, Quittet P, Blood: The Journal of the American Society of Hematology . 2011,第16期

机译：Romiplostim在免疫性血小板减少症中的安全性和有效性在临床实践中：romiplostim慈悲使用程序中72位成人的2年结果。
8. Early life exposure to phthalates and immune response at one year of age in the Canadian healthy Infant Longitudinal Development (CHILD) birth cohort [C] . Tim K. Takaro, Huan Shu, Ryan W. Allen, Annual conference of the International Society of Exposure Science . 2014

机译：加拿大健康的婴儿纵向发育（CHILD）出生队列中的一岁前儿童暴露于邻苯二甲酸盐和免疫应答
9. Primary care physicians' perceptions of the house call for chronic conditions as it relates to quality health care in the patient population 65 years of age and older. [D] . Parkinson, Carrie I. 2012

机译：初级保健医师对房子的看法要求慢性病，因为它与65岁及65岁以上患者人群的优质医疗服务有关。
10. Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies [O] . David J. Kuter, Adrian Newland, Beng H. Chong, -1

机译：新诊断或持续性免疫性血小板减少症（ITP）长达1年的成年患者和慢性ITP超过1年的成年患者中的Romiplostim：来自已完成romiplostim研究的综合数据的亚组分析
11. PSY17 A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO [O] . Arocho R., Northridge K., Rivera Hurtado R., 2011

机译：PSY17 ROMIPLOSTIM（NPLATE®）在墨西哥治疗慢性免疫性血小板减少症（ITP）的药效学评价
12. Field Trial of Meningococcus Group A and 'Haemophilus influenzae' Type B Vaccines in Infants and Children 3 Months to 5 Years of Age: Long Term Sustenance of Immunity After Various Immunization Schedules [R] . Maekelae, P. H. , Peltola, H. , Kaeyhty, H. 1980

机译：婴儿和儿童3个月至5岁的脑膜炎球菌a组和'B型流感嗜血杆菌'疫苗的实地试验：各种免疫接种后的长期免疫保持

romiplostim (NPLATE°) and chronic immune thrombocytopenia from one year of age

摘要

著录项

相似文献

相关主题

期刊订阅